Katharina Modelska

2.8k total citations · 2 hit papers
43 papers, 2.0k citations indexed

About

Katharina Modelska is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Katharina Modelska has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 12 papers in Cancer Research and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Katharina Modelska's work include Prostate Cancer Treatment and Research (18 papers), Cancer, Lipids, and Metabolism (12 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Katharina Modelska is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Cancer, Lipids, and Metabolism (12 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Katharina Modelska collaborates with scholars based in United States, Canada and Italy. Katharina Modelska's co-authors include Jean‐François Pittet, Steven R. Cummings, Fred Saad, Maha Hussain, Cora N. Sternberg, Neal D. Shore, Karim Fizazi, Michael A. Matthay, Ubirajara Ferreira and De Phung and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Katharina Modelska

42 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

2018 677 citations Maha Hussain, Karim Fizazi et al. New England Journal of Medicine profile →
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

2020 266 citations Cora N. Sternberg, Karim Fizazi et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Katharina Modelska

Since Specialization

Citations

This map shows the geographic impact of Katharina Modelska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Modelska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Modelska more than expected).

Fields of papers citing papers by Katharina Modelska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Modelska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Modelska. The network helps show where Katharina Modelska may publish in the future.

Co-authorship network of co-authors of Katharina Modelska

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Modelska. A scholar is included among the top collaborators of Katharina Modelska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Modelska. Katharina Modelska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV). 2024 ·Journal of Clinical Oncology ·(unknown), Kristen Pettit, Joseph J. Shatzel, Abdulraheem Yacoub, Naveen Pemmaraju, Harinder Gill, (unknown), Alessandro Lucchesi, Samah Alimam, Jiří Mayer, Francesca Palandri, Daniel Sasca, Katharina Modelska, Suneel Gupta, (unknown), Sarita Khanna, Arturo Molina, Andrew Kuykendall	1
2	Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study 2023 ·Blood ·Moshe Mittelman, David H. Henry, John A. Glaspy, Anıl Tombak, Rosemary Harrup, Krzysztof Mądry, (unknown), Uwe Platzbecker, Tyson Lee, Katharina Modelska	3
3	Open‐label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non‐myeloid malignancies 2023 ·American Journal of Hematology ·John A. Glaspy, Nashat Gabrail, (unknown), Tyson Lee, Katharina Modelska, (unknown), David H. Henry	11
4	Open-label, phase 2 study of roxadustat for treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies. 2022 ·Journal of Clinical Oncology ·John A. Glaspy, Nashat Gabrail, (unknown), Gopal Saha, Elise Hardy, Tyson Lee, Katharina Modelska, David H. Henry	1
5	Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring 2020 ·European Urology ·Fred Saad, Cora N. Sternberg, Eleni Efstathiou, Karim Fizazi, Katharina Modelska, Xun Lin, Jennifer Sugg, Joyce Steinberg, Bettina Noerby, Neal D. Shore, Maha Hussain	11
6	Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer breakdown → 2020 ·New England Journal of Medicine ·Cora N. Sternberg, Karim Fizazi, Fred Saad, Neal D. Shore, Ugo De Giorgi, David F. Penson, Ubirajara Ferreira, Eleni Efstathiou, Katarzyna Madziarska, Michael Kolinsky, Daniel de Iracema Gomes Cubero, Bettina Noerby, Fabian Zohren, Xun Lin, Katharina Modelska, Jennifer Sugg, Joyce Steinberg, Maha Hussain	266
7	MP52-19 IMPACT OF ENZALUTAMIDE ON PAIN AND HEALTH-RELATED QUALITY OF LIFE IN MEN WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: PROSPER STUDY RESULTS 2018 ·The Journal of Urology ·Fred Saad, David F. Penson, Gerhardt Attard, Maha Hussain, Cora N. Sternberg, (unknown), Katharina Modelska, Eren Demirhan, Krishnan Ramaswamy, Konstantina Skaltsa, Bertrand Tombal	3
8	Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer breakdown → 2018 ·New England Journal of Medicine ·Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal D. Shore, Ubirajara Ferreira, (unknown), Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N. Sternberg	677
9	FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma 2016 ·Vincent J. Picozzi, J. Marc Pipas, Albert C. Koong, Amato J. Giaccia, Nathan Bahary, Smitha Krishnamurthi, Charles D. Lopez, Peter J. O’Dwyer, Katharina Modelska, (unknown), James Chou, Ming Zhong, Stefan Hemmerich, Dongxia Li, Ewa Carrier, Seth Porter, Thomas B. Neff, Frank H. Valone	8
10	EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy 2016 ·Annals of Oncology ·K. Miller, Peter Mulders, Stephen J. Freedland, Howard I. Scher, Neal D. Shore, (unknown), Andrew Krivoshik, D. Phung, Katharina Modelska, Peter T. Scardino	2
11	Prosper: a Phase 3 Study of Enzalutamide in Non-Metastatic (M0) Castration-Resistant Prostate Cancer (Crpc) Patients 2014 ·Annals of Oncology ·Cora N. Sternberg, Karim Fizazi, Fred Saad, Neal D. Shore, Axel Heidenreich, (unknown), Frank Perabo, Zakaria Khondker, Katharina Modelska, Maha Hussain	3
12	Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-d-glutamyl-l-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis 2011 ·Oral Oncology ·Gil Alterovitz, Cynthia Tuthill, (unknown), Katharina Modelska, Stephen T. Sonis	18
13	Endogenous estrogen levels affect sexual function in elderly post-menopausal women 2004 ·Maturitas ·Katharina Modelska, (unknown), Susan K. Ewing, Kristine Yaffe	23
14	Effect of Raloxifene on Urinary Incontinence 2004 ·Obstetrics and Gynecology ·L. Elaine Waetjen, Jeanette S. Brown, Katharina Modelska, Terri Blackwell, Eric Vittinghoff, Steven R. Cummings	32
15	Female sexual dysfunction in postmenopausal women: Systematic review of placebo-controlled trials 2003 ·American Journal of Obstetrics and Gynecology ·Katharina Modelska, Steven R. Cummings	49
16	Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Katharina Modelska, Steven R. Cummings	126
17	Interleukin-8 Mediates Injury from Smoke Inhalation to both the Lung Endothelial and the Alveolar Epithelial Barriers in Rabbits 1999 ·American Journal of Respiratory and Critical Care Medicine ·M. Laffon, Jean‐François Pittet, Katharina Modelska, Michael A. Matthay, David M. Young	77
18	Acid-induced Lung Injury: Protective Effect of Anti-interleukin-8 Pretreatment on Alveolar Epithelial Barrier Function in Rabbits 1999 ·American Journal of Respiratory and Critical Care Medicine ·Katharina Modelska, Jean‐François Pittet, Hans G. Folkesson, V. Courtney Broaddus, Michael A. Matthay	116
19	Comparison of Different Inhalation Schedules to Control Childhood Asthma 1993 ·Birkhäuser Basel eBooks ·Richard Kraemer, Katharina Modelska, (unknown), Martin H. Schöni	7
20	A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease 1992 ·European Journal of Pediatrics ·Richard Kraemer, P. Birrer, Katharina Modelska, (unknown), Martin H. Schöni	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact